End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
286,000 KRW | +1.78% |
|
+6.92% | +190.36% |
2023 | Alteogen Inc. Announces Clinical Trial of Tergase Showed Zero Incidence of ADA | CI |
2023 | ALTEOGEN Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
- Stock Market
- Equities
- A196170 Stock
- News ALTEOGEN Inc.
- Analyst Reco.